Volume | 2,009,363 |
|
|||||
News | - | ||||||
Day High | 737.45 | Low High |
|||||
Day Low | 721.00 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Eli Lilly and Co | LLY | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
724.00 | 721.00 | 737.45 | 733.51 | 724.87 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
72,712 | 2,009,363 | US$ 732.08 | US$ 1,471,009,884 | - | 370.68 - 800.78 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:58:46 | 25 | US$ 733.50 | USD |
Eli Lilly (LLY) Options Flow Summary
Eli Lilly and Co Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
696.96B | 950.16M | - | 34.12B | 5.24B | 5.52 | 133.00 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Eli Lilly News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LLY Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 748.90 | 754.72 | 718.30 | 731.07 | 2,526,506 | -14.89 | -1.99% |
1 Month | 776.00 | 787.8969 | 718.30 | 752.50 | 2,381,790 | -41.99 | -5.41% |
3 Months | 661.50 | 800.78 | 659.735 | 752.53 | 3,073,617 | 72.51 | 10.96% |
6 Months | 580.00 | 800.78 | 547.61 | 670.21 | 3,094,588 | 154.01 | 26.55% |
1 Year | 382.69 | 800.78 | 370.68 | 584.16 | 3,050,958 | 351.32 | 91.80% |
3 Years | 188.57 | 800.78 | 178.5779 | 388.12 | 2,996,628 | 545.44 | 289.25% |
5 Years | 118.87 | 800.78 | 101.36 | 275.68 | 3,331,543 | 615.14 | 517.49% |
Eli Lilly Description
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. |